Product Information
HYOSCYAMINE ER 0.375 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.5356 per EA under NDC 62559042301. Its NADAC has been published 120 times since Jun 19, 2024.
Strength
.375 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559042301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
2/15/2024
Price Statistics
The NADAC for HYOSCYAMINE ER 0.375 MG TAB has been published 120 times since Jun 19, 2024, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5356 per EA |
|---|---|
| All-time high | $0.9112 (May 14, 2025) |
| All-time low | $0.4910 (Jun 17, 2026) |
| 52-week high | $0.5884 |
| 52-week low | $0.4910 |
| Median price | $0.5884 |
| Average price | $0.6914 |
| Largest weekly change | -24.5% (Jul 23, 2025) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hyoscyamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hyoscyamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYOSCYAMINE ER 0.375 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYOSCYAMINE ER 0.375 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.5356 per EA (NDC 62559042301), effective Sep 30, 2026.
How has the price of HYOSCYAMINE ER 0.375 MG TAB changed over time?
Over the history we have for it, the NADAC for HYOSCYAMINE ER 0.375 MG TAB has declined 38.3%. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for HYOSCYAMINE ER 0.375 MG TAB?
Since Jun 19, 2024, the NADAC for HYOSCYAMINE ER 0.375 MG TAB has ranged from a low of $0.4910 (Jun 17, 2026) to a high of $0.9112 (May 14, 2025), with a median of $0.5884 per EA.
Are there cheaper alternatives to HYOSCYAMINE ER 0.375 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of HYOSCYAMINE ER 0.375 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYOSCYAMINE ER 0.375 MG TAB?
HYOSCYAMINE ER 0.375 MG TAB (NDC 62559042301) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.